MOLECULAR & CELLULAR TOXICOLOGY
Instructions for Authors
Molecular & Cellular Toxicology (MCT)
Molecular & Cellular Toxicology (MCT) is owned and published by The Korean Society of Toxicogenomics and Toxicoproteomics (KSTT). The journal is published four times a year in a printed and electronic forms. Its editorial policies are the responsibility of the editor, the associate editors, and the editorial board under the general authority of the Publications Committee and the Council.
Scope of Journal
MCT publishes original Research Articles, and Mini Reviews in all areas of the complex interaction between the cell’s genome, chemicals in the environment, and disease. Acceptable manuscripts are the ones that deal with some topics of toxicology, including those that lie in the domains of analytical chemistry, biochemistry, pharmacology, genomics, epigenomics, proteomics, bioinformatics and environmental biology with the aspects of molecular and cellular levels. Emphasis will be placed on toxic effects observed at relevant genomics and proteomics, which have direct impact on drug development, environmental health, public health policy, food safety, forensic medicine, and preventive medicine.
Publication Ethics
Manuscripts submitted for publication must contain a statement to the effect that all human studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.
The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements. Experiments causing pain or discomfort to animals must be performed according to the guidelines of the International Association for the Study of Pain as published in Pain 1983; 16:109-110. In accordance with these guidelines, authors performing such experiments must justify explicitly that the procedures used are scientifically necessary and that the minimum possible pain or stress has been imposed on the animals. For all animal studies which extend beyond a first hypothesis generation, a sample size calculation should be provided. Authors should also indicate whether the experimental work was reviewed by an ethics committee or its equivalent.
Other ethical considerations should be in keeping with the most recent guidelines of the International Committee of Medical Journal Editors (www.icmje.org). In addition, a statement must be provided as part of a covering letter, signed by all authors, which approves the manuscript for publication, states that the manuscript has not been published in part or as a whole elsewhere and indicates source(s) of funding and absence of any possible conflicts of interest.
Clinical trials should be presented in accordance with the revised CONSORT statement as published in several leading journals (e.g. http://www.biomedcentral. com/1471-2288/1/2). As outlined in this statement, a patient flow chart should be included in all clinical trials submitted for publication.
The MCT journal is a part of iThenticate, which is an initiative to help editors verify the originality
of submitted manuscripts. Every manuscript will be submitted to the program to compare with the database.
Types of papers
Two types of manuscripts are accepted, full-length research articles and mini reviews. Authors are urged to keep the length of manuscripts below eight printed pages for research articles and mini reviews (24 typed pages of manuscript in double spacing including figures and tables). All mini reviews are by invitation only, and subjects are chosen by the MCT editors.
Language of paper
All manuscripts should be written in English. Authors, who are unsure of proper English usage, should have their manuscripts checked by someone with English proficiency (or native English speaker).
Manuscripts may be editorially rejected, without review, on the basis of poor English or lack of conformity to the standards set forth in these Instructions.
All manuscripts submitted for publications will be screened for English by the professional English editor in MCT.
Publication charges
Corresponding authors of articles accepted for publication will receive an email notifying them how to pay page and any other applicable publication charges before publication.
● Publication charges: Corresponding author will be charged
￦700,000 (Paid member from Korea)
￦800,000 (Non-paid member from Korea)
￦900,000 (Non-member from Korea)
US$800 (Overseas)
US$3,280 (Open Choice)
per article after final acceptance. Non-member corresponding authors may join KSTT to obtain discounts on publications charges. Authors may join KSTT and renew or upgrade membership.
● Open Choice:
Open Choice allows you to publish open access in more than 1900 Springer Nature journals, making your research more visible and accessible immediately on publication.
Benefits:
• Increased researcher engagement: Open Choice enables access by anyone with an internet connection, immediately on publication.
• Higher visibility and impact: In Springer hybrid journals, OA articles are accessed 4 times more often on average, and cited 1.6 more times on average*.
• Easy compliance with funder and institutional mandates: Many funders require open access publishing, and some take compliance into account when assessing future grant applications.
……
更多详情：
https://www.springer.com/journal/13273/submission-guidelines
